Zimmer Biomet Holdings (ZBH) Cash from Operations (2009 - 2026)

Zimmer Biomet Holdings' Cash from Operations history runs 18 years deep, the most recent figure standing at 359400000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations fell 6.11% year-over-year to 359400000.0 in Q1 2026; TTM through Mar 2026 was 1673700000.0, a 1.18% increase from a year earlier, with the FY2025 full-year figure at 1697100000.0, up 13.19% from the prior year.
• Cash from Operations fell to 359400000.0 in Q1 2026 per ZBH's latest filing, from 517400000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 588400000.0 in Q4 2023 and bottomed at 228000000.0 in Q1 2024.
• The 5-year median for Cash from Operations is 369400000.0 (2024), against an average of 381982352.94.
• Across the five-year window, Cash from Operations declined 27.67% in 2022 and soared 140.95% in 2023, its largest moves.
• Year by year, Cash from Operations stood at 244200000.0 in 2022, then surged by 140.95% to 588400000.0 in 2023, then slipped by 13.95% to 506300000.0 in 2024, then rose by 2.19% to 517400000.0 in 2025, then sank by 30.54% to 359400000.0 in 2026.
• Per Business Quant, the three latest ZBH Cash from Operations figures stand at 359400000.0 (Q1 2026), 517400000.0 (Q4 2025), and 418700000.0 (Q3 2025).